<?xml version="1.0" encoding="UTF-8"?>
<p>In a recent paper [
 <xref ref-type="bibr" rid="CR24">24</xref>], patient level information such as mutation profiles is incorporated to identify protein-protein interaction (PPI) interfaces enriched in somatic mutations. It will be interesting to explore how to incorporate patient heterogeneity information into our approach.
</p>
